The genetic basis of common human diseases. Linkage as applied to the human genome. Techniques for gene mapping. Cytogenetics and its use in the clinic. Mendelian disorders and the genetics of complex diseases with particular reference to diabetes and cancer. Clinical human genetics including ethical considerations. Genetic counselling.
GENE 313 aims to give a broad overview on how genetics impacts upon medical practice today and aims to anticipate developments into the future. Material is presented that explores how the genetic basis of single-gene Mendelian disorders, complex traits, cancer and epigenetic mechanisms are characterised and then employed clinically in medical practice. The lecture course is complemented by a laboratory course that gives hands-on experience of many of the methods that are used diagnostically including karyotypic analysis, medical bioinformatics, DNA sequence analysis, association analysis and characterisation of epigenetic anomalies.
|Paper title||Medical Genetics|
|Teaching period||Second Semester|
|Domestic Tuition Fees (NZD)||$1,038.45|
|International Tuition Fees (NZD)||$4,680.00|
- GENE 221, GENE 222, GENE 223
- Schedule C
- i) In approved cases, another 200-level biological sciences paper may be substituted for one of GENE 221-223. (ii) This paper includes additional non-streamed lab time that does not appear in the timetable. Please contact the department for further details.
- Appropriate for students majoring in genetics, other biological and health sciences and molecular biotechnology.
- More information link
- View more information on the Genetics programme's website
- Teaching staff
- Convenor: Professor Stephen Robertson
(Department of Pathology)
Other teaching staff: Dr David Markie (Department of Pathology), Dr Anita Dunbier (Department of Biochemistry), Professor Tony Merriman (Department of Biochemistry), Professor Ian Morison(Department of Pathology) and Dr Gillian Mackay (Genetics Programme)
- Paper Structure
- The lecture course is divided into five themes:
- Pedigrees analysis
- Chromosomal analysis and Molecular karyotyping
- Mutations and disease
- Next generation sequencing and its application to medicine
- Teaching Arrangements
- All labs are held in Room G09, Biochemistry building.
- Text books are not required for this paper.
Two books that might be helpful are:
Human Molecular Genetics. T. Strachan and A.P. Read. 4th edn, New York; Wiley 2010.
New Clinical Genetics 3rd edition, Andrew Read and Dian Donnai
Most important is the supplementary reading material that is lodged on Blackboard as indicated by course teachers. A reading list is also to be found in the course handbook
- Course outline
- View the information sheet for GENE 313
- Graduate Attributes Emphasised
- Global perspective, Interdisciplinary perspective, Lifelong learning, Scholarship,
Critical thinking, Cultural understanding, Ethics, Information literacy, Research,
View more information about Otago's graduate attributes.
- Learning Outcomes
- The broad objectives of GENE 313 are to:
- Understand patterns of single-gene inheritance, the molecular basis of various DNA-based polymorphisms, the principles of linkage and the challenges that massively parallel sequencing technology, interpretation of karyotypes, chromosomal abnormalities and genomic disorders bring to clinical practice
- Understand how genetic conditions present clinically; what the clinical issues are and how they are resolved and communicated to families; what the future of genetics is in medicine; the aetiology of complex disease and, in particular, the interplay between genes and environment
- Be conversant with the design considerations as applied to association analysis, specifically candidate gene approaches and whole-genome screening
- Understand some of the molecular mechanisms that contribute to the development of cancer, in particular the role of oncogenes and tumour-suppressor genes, and to develop an appreciation of how genetic/molecular information may be used in the development of diagnostics and therapeutics
- Develop an awareness that epigenetics impacts on disease expression over the human lifespan